Literature DB >> 12238829

Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting.

Zoltán Szabó, Erik Håkanson, Rolf Svedjeholm.   

Abstract

BACKGROUND: An increasing proportion of patients undergoing coronary artery bypass grafting (CABG) are diabetics. Patient characteristics, early postoperative outcome, and midterm survival in diabetic patients after CABG were investigated.
METHODS: A total of 2779 consecutive patients undergoing isolated CABG during 1995 to 1999 were studied, 19.4% of whom had diabetes mellitus. Demographic and peri-procedural data were registered prospectively in a computerized institutional database.
RESULTS: The diabetic group was younger and included a higher proportion of women, and patients with hypertension, triple-vessel disease, and unstable angina. They required a higher number of bypasses, and longer cross-clamp and cardiopulmonary bypass times. Intensive care unit and hospital stays were prolonged and the need for inotropic agents, hemotransfusions, and dialysis was higher in the diabetic group. Renal failure, stroke (4.3% versus 1.7%), mediastinitis, and wound infections were more frequently encountered. Thirty-day mortality was 2.6% versus 1.6% (p = 0.15). Cumulative 5-year survival was 84.4% versus 91.3% (p < 0.001).
CONCLUSIONS: Short-term mortality was acceptable in diabetic patients after CABG but they had increased postoperative morbidity in comparison with nondiabetic patients, particularly with regard to renal function, cerebral complications, and infections. Midterm survival was impaired in diabetic patients mainly because of a less favorable outcome in patients treated with insulin.

Entities:  

Mesh:

Year:  2002        PMID: 12238829     DOI: 10.1016/s0003-4975(02)03778-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  33 in total

Review 1.  Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus.

Authors:  Yuji Kadoi
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

Review 2.  Perioperative Management of Diabetes Mellitus: Novel Approaches.

Authors:  Nadine E Palermo; Rajesh Garg
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

3.  The CARDia trial protocol.

Authors:  D Smith
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 4.  Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.

Authors:  Rodolfo J Galindo; Maya Fayfman; Guillermo E Umpierrez
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

5.  Postoperative glycemic control in cardiac surgery patients.

Authors:  Theresa Breithaupt
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-01

6.  Coronary revascularization in diabetic patients: Current state of evidence.

Authors:  Mukesh Singh; Rohit Arora; Vamsi Kodumuri; Sandeep Khosla; Evyan Jawad
Journal:  Exp Clin Cardiol       Date:  2011

7.  Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery.

Authors:  Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Atsushi Kambara; Keiji Matsubayashi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

8.  Insulin-Based Infusion System: Advancing the Development.

Authors:  Nasseh Hashemi; Tim Valk; Kim Houlind; Niels Ejskjaer
Journal:  J Diabetes Sci Technol       Date:  2019-03-10

9.  Coronary bypass before simultaneous pancreas-kidney transplants for type 1 diabetics in renal failure.

Authors:  J Ernesto Molina; David E R Sutherland; Yang Wang; Angelika C Gruessner; Barbara J Bland
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

10.  Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry.

Authors:  William G Cotts; Edwin C McGee; Susan L Myers; David C Naftel; James B Young; James K Kirklin; Kathleen L Grady
Journal:  J Heart Lung Transplant       Date:  2014-03-01       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.